A systematic review of adverse drug events associated with administration of common asthma medications in children.

A systematic review of adverse drug events associated with administration of common asthma medications in children.

<h4>Objective</h4>To systematically review the literature and determine frequencies of adverse drug events (ADE) associated with pediatric asthma medications.<h4>Methods</h4>Following PRISMA guidelines, we systematically searched six bibliographic databases between January 19...

Full description

Saved in:

Bibliographic Details
Main Authors:	James S Leung, David W Johnson, Arissa J Sperou, Jennifer Crotts, Erik Saude, Lisa Hartling, Antonia Stang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0182738
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse events related to emergency department care: a systematic review.
by: Antonia S Stang, et al.
Published: (2013-01-01)

An Exploratory Research to Evaluate the 30 Most Common Pulmonary Embolism Drugs in the Food and Drug Administration Adverse Event Reporting System
by: Hang Chen, et al.
Published: (2025-06-01)

Reporting Adverse Drug Events in Drug Administration Process among Nursing Personnel
by: Katarzyna Kwiecień-Jaguś, et al.
Published: (2022-06-01)

ICD-10 Codes to Identify Adverse Drug Events Associated with Antibiotics in Administrative Data
by: Hannah Lishman, et al.
Published: (2025-03-01)

Analysis of the relationship between antineoplastic drugs and suicide-related adverse events based on the food and drug administration adverse event reporting system database
by: Nan Zhao, et al.
Published: (2024-12-01)

Analysis of Adverse Events Associated With Dental Local Anaesthetics Using Food and Drug Administration Adverse Event Reporting System Data
by: Ferit Bayram, et al.
Published: (2025-06-01)

Safety assessment of ripretinib: a real-world adverse event analysis from the food and drug administration adverse event reporting system
by: Sentai Wang, et al.
Published: (2025-03-01)

Adverse drug reaction to tremelimumab and durvalumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database
by: Wei Fan Sui, et al.
Published: (2025-08-01)

Risk Assessment of Linezolid-Associated Neurological Adverse Drug Reactions Based on the Food and Drug Administration Adverse Event Reporting System Database
by: Yin J, et al.
Published: (2025-05-01)

Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
by: Runan Fang, et al.
Published: (2024-11-01)

Adverse drug reactions to atezolizumab in combination with bevacizumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database
by: Wanming He, et al.
Published: (2025-02-01)

Cardiovascular Adverse Events Associated with Prostate Cancer Treatment: A Disproportionality Analysis from the Food and Drug Administration Adverse Event Reporting System Database
by: Connor Frey
Published: (2024-11-01)

How Safe Are Common Analgesics for the Treatment of Acute Pain for Children? A Systematic Review
by: Lisa Hartling, et al.
Published: (2016-01-01)

Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors
by: Shaili Tapiavala, et al.
Published: (2025-08-01)

Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database
by: Wen-Hui Liu, et al.
Published: (2024-11-01)

Review of common cutaneous adverse drug reactions
by: M.H. Motswaledi
Published: (2005-07-01)

Comparing drug combinations for graft-versus-host disease prophylaxis using the U.S. Food and Drug Administration Adverse Event Reporting System
by: Toru Ogura, et al.
Published: (2025-06-01)

Comparison of active versus passive surveillance adverse event reporting in a paediatric ambulatory chiropractic care setting: a cluster randomised controlled trial
by: Lisa Hartling, et al.
Published: (2020-11-01)

Using administrative databases for parmacoepidemiological monitoring of asthma drug prescribing
by: Ye. V. Karakulova, et al.
Published: (2009-08-01)

Rare Adverse Events of CAR T-Cell Therapy
by: Antonia Müller
Published: (2024-03-01)

Common adverse cutaneous drug reaction patterns and the causative drugs in Malaysia
by: N. H. Talib, et al.
Published: (2015-07-01)

Pretrained patient trajectories for adverse drug event prediction using common data model-based electronic health records
by: Junmo Kim, et al.
Published: (2025-06-01)

Cost savings of EMS administration of bronchodilators and systemic corticosteroids for pediatric asthma patients
by: Jennifer Fishe, et al.
Published: (2025-08-01)

Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system.
by: Yun Kim, et al.
Published: (2025-01-01)

Abemaciclib-associated kidney injuries: A retrospective analysis of the United States Food and Drug Administration adverse events reporting system
by: Xiangchun Xu, et al.
Published: (2025-03-01)

Exploring Human Misuse and Abuse of Veterinary Drugs: A Descriptive Pharmacovigilance Analysis Utilising the Food and Drug Administration’s Adverse Events Reporting System (FAERS)
by: Josie Dunn, et al.
Published: (2024-10-01)

Using multiple drug similarity networks to promote adverse drug event detection
by: Biswajit Padhi, et al.
Published: (2024-11-01)

A pharmacovigilance study of the association between linaclotide/plecanatide and muscle spasms based on food and drug administration adverse event reporting system
by: Xue Fan, et al.
Published: (2025-08-01)

Safety Evaluation of the Combination with Dexrazoxane and Anthracyclines: A Disproportionality Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database
by: Danyi Liu, et al.
Published: (2024-12-01)

Diabetic Ketoacidosis and the Use of New Hypoglycemic Groups: Real-World Evidence Utilizing the Food and Drug Administration Adverse Event Reporting System
by: Hilal A. Thaibah, et al.
Published: (2025-02-01)

Safety of creatine supplementation: Analysis of Adverse Events reported in clinical trials and adverse event reports
by: Sarah E. Johnson, et al.
Published: (2025-09-01)

ADVERSE EVENTS FOLLOWING PENTAVALENT VACCINE ADMINISTRATION: A DESCRIPTIVE STUDY IN THE INDIAN CONTEXT
by: Roop Sharma, et al.
Published: (2025-05-01)

Weight Loss in Cancer and the 2017 Common Terminology Criteria for Adverse Events—Dangerous and Misleading
by: Aynur Aktas, et al.
Published: (2025-04-01)

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report
by: Zheng Wang, et al.
Published: (2025-08-01)

Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report)
by: G. S. Krasnov, et al.
Published: (2018-11-01)

A call to action for adverse drug event (ADE) detection and prevention
by: John McCue, et al.
Published: (2025-03-01)

Treatment-related adverse events of antibody drug-conjugates in clinical trials
by: Harold Nathan Tan, et al.
Published: (2025-07-01)

Evaluating knowledge fusion models on detecting adverse drug events in text.
by: Philipp Wegner, et al.
Published: (2025-03-01)

Analysis of the notifications of adverse drug events in a Brazilian public hospital
by: Larissa Duarte SANTOS, et al.
Published: (2024-12-01)

Descriptive analysis of the national drug adverse events (AEs) database in Lebanon
by: Rita Karam, et al.
Published: (2025-12-01)